Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Mechanism of Action Study for Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 mechanism-of-action study in psoriasis completed; results have been posted by Tufts Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tufts Medical Center | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2017-07-02